Related references
Note: Only part of the references are listed.Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials
J. Pundir et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters
U. Durmus et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
Mojca Jensterle et al.
BMC ENDOCRINE DISORDERS (2017)
Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential
Malin Nylander et al.
ENDOCRINE CONNECTIONS (2017)
Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes
Gulay Simsek Bagir et al.
MEDICAL PRINCIPLES AND PRACTICE (2016)
The Impact of Bariatric Surgery on Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
Daniel Skubleny et al.
OBESITY SURGERY (2016)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY
W. Timothy Garvey et al.
ENDOCRINE PRACTICE (2016)
Polycystic Ovary Syndrome
Giovanni Targher
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Polycystic Ovary Syndrome
Christopher R. McCartney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study
Mojca Jensterle et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
Daniel A. Dumesic et al.
ENDOCRINE REVIEWS (2015)
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications
Bruno Halpern et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis
Negar Naderpoor et al.
HUMAN REPRODUCTION UPDATE (2015)
Efficacy Comparison of Medications Approved for Chronic Weight Management
Rekha B. Kumar et al.
OBESITY (2015)
Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study
Mojca Jensterle et al.
JOURNAL OF OVARIAN RESEARCH (2015)
Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome
Mojca Jensterle et al.
ENDOCRINE RESEARCH (2015)
A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
Mojca Jensterle et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2015)
Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial
Ashraf Moini et al.
ENDOCRINE (2015)
Visualizing inconsistency in network meta-analysis by independent path decomposition
Ulrike Krahn et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
Mojca Jensterle Sever et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis
John A. Barry et al.
HUMAN REPRODUCTION UPDATE (2014)
New and Emerging Drug Molecules Against Obesity
Melvin George et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
The Rationale of the Myo-Inositol and D-Chiro-Inositol Combined Treatment for Polycystic Ovary Syndrome
Simona Dinicola et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
A graphical tool for locating inconsistency in network meta-analyses
Ulrike Krahn et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
Metformin decreases serum 8-hydroxy-2′-deoxyguanosine levels in polycystic ovary syndrome
Henri Sova et al.
FERTILITY AND STERILITY (2013)
Diet, physical exercise and Orlistat administration increase serum Anti-Mullerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)
Christos Vosnakis et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis
S. S. Lim et al.
OBESITY REVIEWS (2013)
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
S. S. Lim et al.
HUMAN REPRODUCTION UPDATE (2012)
Obesity and PCOS: Implications for Diagnosis and Treatment
Richard S. Legro
SEMINARS IN REPRODUCTIVE MEDICINE (2012)
Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome
Renato Pasquali et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study
Gwinnett Ladson et al.
FERTILITY AND STERILITY (2011)
Exercise therapy in polycystic ovary syndrome: a systematic review
Cheryce L. Harrison et al.
HUMAN REPRODUCTION UPDATE (2011)
The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study
Sedigheh Ghandi et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2011)
Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline
Helena J. Teede et al.
MEDICAL JOURNAL OF AUSTRALIA (2011)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome
L. W. Cho et al.
CLINICAL ENDOCRINOLOGY (2009)
An RCT of metformin versus orlistat for the management of obese anovulatory women
M. Metwally et al.
HUMAN REPRODUCTION (2009)
Introduction to Meta-Analysis by Michael Borenstein, Larry V. Hedges, Julian P.T. Higgins, Hannah R. Rothstein
Andreas Rosenblad
INTERNATIONAL STATISTICAL REVIEW (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels
Dimitrios Panidis et al.
FERTILITY AND STERILITY (2008)
The Impact of Metformin, Oral Contraceptives, and Lifestyle Modification on Polycystic Ovary Syndrome in Obese Adolescent Women in Two Randomized, Placebo-Controlled Clinical Trials
Kathleen Hoeger et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Cost-Effectiveness of a Low-Calorie Diet and Orlistat for Obese Persons: Modeling Long-Term Health Gains through Prevention of Obesity-Related Chronic Diseases
Pieter H. M. van Baal et al.
VALUE IN HEALTH (2008)
Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome
Mariana Toscani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: A randomized, 12-month, placebo-controlled study
Alessandra Gambineri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study
T Tang et al.
HUMAN REPRODUCTION (2006)
Orlistat: A review of its use in the management of obesity
Sheridan Henness et al.
DRUGS (2006)
Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy:: Obese, lean, hyper or normoinsulinemic?
G Önalan et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2005)
Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome
V Jayagopal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin
GAR Maciel et al.
FERTILITY AND STERILITY (2004)
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome
A Gambineri et al.
CLINICAL ENDOCRINOLOGY (2004)
Self-regulation of energy intake in the prevention and treatment of obesity: Is it feasible?
MR Lowe
OBESITY RESEARCH (2003)
Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome
CJ Glueck et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome
L Harborne et al.
LANCET (2003)
Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: A randomized, double-blind and placebo-controlled trial
KH Chou et al.
HORMONE AND METABOLIC RESEARCH (2003)
Share Paper
